Literature DB >> 28453189

Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update.

Priya Patel1,2, Paula D Robinson3, Jennifer Thackray4, Jacqueline Flank1, Mark T Holdsworth5, Paul Gibson6, Andrea Orsey7,8, Carol Portwine9, Jason Freedman10,11, Jennifer R Madden12, Robert Phillips13,14, Lillian Sung15,16, L Lee Dupuis1,2,16.   

Abstract

This update of the 2013 clinical practice guideline provides clinicians with guidance regarding the use of aprepitant and palonosetron for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) in children. The recommendations were based on three systematic reviews. Substantive changes were made to the guideline recommendations including the inclusion of palonosetron to the 5-HT3 antagonists recommended for children receiving highly emetogenic chemotherapy (HEC) and the recommendation of aprepitant for children 6 months of age or older receiving HEC. To optimize CINV control in children, future work must focus on closing critical research gaps.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemotherapy; guideline; nausea; pediatrics; supportive care; vomiting

Mesh：

Substances：

Year:  2017        PMID： 28453189     DOI： 10.1002/pbc.26542

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  17 in total

1.  Chemotherapy-induced nausea and vomiting control in pediatric patients receiving ifosfamide plus etoposide: a prospective, observational study.

Authors:  Priya Patel; Sara R Lavoratore; Jacqueline Flank; Meaghan Kemp; Ashlee Vennettilli; Helen Vol; Tracey Taylor; Elyse Zelunka; Anne Marie Maloney; Paul C Nathan; L Lee Dupuis
Journal:  Support Care Cancer       Date:  2019-06-08       Impact factor: 3.603

2.  A randomized, open-label non-inferiority study to compare palonosetron and ondansetron for prevention of acute chemotherapy-induced vomiting in children with cancer receiving moderate or high emetogenic chemotherapy.

Authors:  Sandeep Jain; Gauri Kapoor; Sahitya Koneru; Gayatri Vishwakarma
Journal:  Support Care Cancer       Date:  2018-03-22       Impact factor: 3.603

Review 3.  Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.

Authors:  L Lee Dupuis; Sabrina Boodhan; Lillian Sung; Carol Portwine; Richard Hain; Patricia McCarthy; Mark Holdsworth
Journal:  Pediatr Blood Cancer       Date:  2011-04-04       Impact factor: 3.167

4.  Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.

Authors:  Jennifer Seelisch; Lillian Sung; Michael J Kelly; Jennifer L Raybin; Melissa Beauchemin; Christopher C Dvorak; Katherine Patterson Kelly; Michael L Nieder; Robert B Noll; Jennifer Thackray; Nicole J Ullrich; Sandra Cabral; L Lee Dupuis; Paula D Robinson
Journal:  Pediatr Blood Cancer       Date:  2018-09-26       Impact factor: 3.167

5.  Data Quality of Chemotherapy-Induced Nausea and Vomiting Documentation.

Authors:  Melissa Beauchemin; Chunhua Weng; Lillian Sung; Adrienne Pichon; Maura Abbott; Dawn L Hershman; Rebecca Schnall
Journal:  Appl Clin Inform       Date:  2021-04-21       Impact factor: 2.342

6.  Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process.

Authors:  Astrid Eliasen; Mikkel Kramme Abildtoft; Niels Steen Krogh; Catherine Rechnitzer; Jesper Sune Brok; René Mathiasen; Kjeld Schmiegelow; Kim Peder Dalhoff
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-20       Impact factor: 4.773

7.  Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.

Authors:  Giovanna Giagnuolo; Salvatore Buffardi; Francesca Rossi; Fara Petruzziello; Chiara Tortora; Isabella Buffardi; Nicoletta Marra; Giuliana Beneduce; Giuseppe Menna; Rosanna Parasole
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

8.  Dronabinol Prescribing and Exposure Among Children and Young Adults Diagnosed with Cancer.

Authors:  Joseph E Rower; Amber D King; Diana Wilkins; Jacob Wilkes; Venkata Yellepeddi; Luke Maese; Richard S Lemons; Jonathan E Constance
Journal:  J Adolesc Young Adult Oncol       Date:  2020-07-14       Impact factor: 2.223

9.  Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment.

Authors:  Antonio Ruggiero; Daniela Rizzo; Martina Catalano; Paola Coccia; Silvia Triarico; Giorgio Attiná
Journal:  J Int Med Res       Date:  2018-04-24       Impact factor: 1.671

10.  Emergency Department Chief Complaints Among Children With Cancer.

Authors:  Megan D Burcham; Anneli R Cochrane; Seethal A Jacob; Aaron E Carroll; Emily L Mueller
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.